Molecular Basis of Bacillus subtilis ATCC 6633 Self-Resistance to the Phosphono-oligopeptide Antibiotic Rhizocticin

Nektaria Petronikolou, Manuel A. Ortega, Svetlana A. Borisova, Satish K Nair, William W Metcalf

Research output: Contribution to journalArticle

Abstract

Rhizocticins are phosphono-oligopeptide antibiotics that contain a toxic C-terminal (Z)-l-2-amino-5-phosphono-3-pentenoic acid (APPA) moiety. APPA is an irreversible inhibitor of threonine synthase (ThrC), a pyridoxal 5′-phosphate (PLP)-dependent enzyme that catalyzes the conversion of O-phospho-l-homoserine to l-threonine. ThrCs are essential for the viability of bacteria, plants, and fungi and are a target for antibiotic development, as de novo threonine biosynthetic pathway is not found in humans. Given the ability of APPA to interfere in threonine metabolism, it is unclear how the producing strain B. subtilis ATCC 6633 circumvents APPA toxicity. Notably, in addition to the housekeeping APPA-sensitive ThrC (BsThrC), B. subtilis encodes a second threonine synthase (RhiB) encoded within the rhizocticin biosynthetic gene cluster. Kinetic and spectroscopic analyses show that PLP-dependent RhiB is an authentic threonine synthase, converting O-phospho-l-homoserine to threonine with a catalytic efficiency comparable to BsThrC. To understand the structural basis of inhibition, we determined the crystal structure of APPA bound to the housekeeping BsThrC, revealing a covalent complex between the inhibitor and PLP. Structure-based sequence analyses reveal structural determinants within the RhiB active site that contribute to rendering this ThrC homologue resistant to APPA. Together, this work establishes the self-resistance mechanism utilized by B. subtilis ATCC 6633 against APPA exemplifying one of many ways by which bacteria can overcome phosphonate toxicity.

Original languageEnglish (US)
Pages (from-to)742-750
Number of pages9
JournalACS chemical biology
Volume14
Issue number4
DOIs
StatePublished - Apr 19 2019

Fingerprint

Oligopeptides
Bacilli
Bacillus subtilis
Anti-Bacterial Agents
Threonine
Pyridoxal Phosphate
Homoserine
Housekeeping
Toxicity
Bacteria
Microbial Viability
Organophosphonates
2-amino-5-phosphono-3-pentenoic acid
Poisons
Biosynthetic Pathways
Multigene Family
Fungi
Metabolism
Sequence Analysis
Catalytic Domain

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Molecular Basis of Bacillus subtilis ATCC 6633 Self-Resistance to the Phosphono-oligopeptide Antibiotic Rhizocticin. / Petronikolou, Nektaria; Ortega, Manuel A.; Borisova, Svetlana A.; Nair, Satish K; Metcalf, William W.

In: ACS chemical biology, Vol. 14, No. 4, 19.04.2019, p. 742-750.

Research output: Contribution to journalArticle

@article{a3f8885f77cc45219b4745da7785b030,
title = "Molecular Basis of Bacillus subtilis ATCC 6633 Self-Resistance to the Phosphono-oligopeptide Antibiotic Rhizocticin",
abstract = "Rhizocticins are phosphono-oligopeptide antibiotics that contain a toxic C-terminal (Z)-l-2-amino-5-phosphono-3-pentenoic acid (APPA) moiety. APPA is an irreversible inhibitor of threonine synthase (ThrC), a pyridoxal 5′-phosphate (PLP)-dependent enzyme that catalyzes the conversion of O-phospho-l-homoserine to l-threonine. ThrCs are essential for the viability of bacteria, plants, and fungi and are a target for antibiotic development, as de novo threonine biosynthetic pathway is not found in humans. Given the ability of APPA to interfere in threonine metabolism, it is unclear how the producing strain B. subtilis ATCC 6633 circumvents APPA toxicity. Notably, in addition to the housekeeping APPA-sensitive ThrC (BsThrC), B. subtilis encodes a second threonine synthase (RhiB) encoded within the rhizocticin biosynthetic gene cluster. Kinetic and spectroscopic analyses show that PLP-dependent RhiB is an authentic threonine synthase, converting O-phospho-l-homoserine to threonine with a catalytic efficiency comparable to BsThrC. To understand the structural basis of inhibition, we determined the crystal structure of APPA bound to the housekeeping BsThrC, revealing a covalent complex between the inhibitor and PLP. Structure-based sequence analyses reveal structural determinants within the RhiB active site that contribute to rendering this ThrC homologue resistant to APPA. Together, this work establishes the self-resistance mechanism utilized by B. subtilis ATCC 6633 against APPA exemplifying one of many ways by which bacteria can overcome phosphonate toxicity.",
author = "Nektaria Petronikolou and Ortega, {Manuel A.} and Borisova, {Svetlana A.} and Nair, {Satish K} and Metcalf, {William W}",
year = "2019",
month = "4",
day = "19",
doi = "10.1021/acschembio.9b00030",
language = "English (US)",
volume = "14",
pages = "742--750",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Molecular Basis of Bacillus subtilis ATCC 6633 Self-Resistance to the Phosphono-oligopeptide Antibiotic Rhizocticin

AU - Petronikolou, Nektaria

AU - Ortega, Manuel A.

AU - Borisova, Svetlana A.

AU - Nair, Satish K

AU - Metcalf, William W

PY - 2019/4/19

Y1 - 2019/4/19

N2 - Rhizocticins are phosphono-oligopeptide antibiotics that contain a toxic C-terminal (Z)-l-2-amino-5-phosphono-3-pentenoic acid (APPA) moiety. APPA is an irreversible inhibitor of threonine synthase (ThrC), a pyridoxal 5′-phosphate (PLP)-dependent enzyme that catalyzes the conversion of O-phospho-l-homoserine to l-threonine. ThrCs are essential for the viability of bacteria, plants, and fungi and are a target for antibiotic development, as de novo threonine biosynthetic pathway is not found in humans. Given the ability of APPA to interfere in threonine metabolism, it is unclear how the producing strain B. subtilis ATCC 6633 circumvents APPA toxicity. Notably, in addition to the housekeeping APPA-sensitive ThrC (BsThrC), B. subtilis encodes a second threonine synthase (RhiB) encoded within the rhizocticin biosynthetic gene cluster. Kinetic and spectroscopic analyses show that PLP-dependent RhiB is an authentic threonine synthase, converting O-phospho-l-homoserine to threonine with a catalytic efficiency comparable to BsThrC. To understand the structural basis of inhibition, we determined the crystal structure of APPA bound to the housekeeping BsThrC, revealing a covalent complex between the inhibitor and PLP. Structure-based sequence analyses reveal structural determinants within the RhiB active site that contribute to rendering this ThrC homologue resistant to APPA. Together, this work establishes the self-resistance mechanism utilized by B. subtilis ATCC 6633 against APPA exemplifying one of many ways by which bacteria can overcome phosphonate toxicity.

AB - Rhizocticins are phosphono-oligopeptide antibiotics that contain a toxic C-terminal (Z)-l-2-amino-5-phosphono-3-pentenoic acid (APPA) moiety. APPA is an irreversible inhibitor of threonine synthase (ThrC), a pyridoxal 5′-phosphate (PLP)-dependent enzyme that catalyzes the conversion of O-phospho-l-homoserine to l-threonine. ThrCs are essential for the viability of bacteria, plants, and fungi and are a target for antibiotic development, as de novo threonine biosynthetic pathway is not found in humans. Given the ability of APPA to interfere in threonine metabolism, it is unclear how the producing strain B. subtilis ATCC 6633 circumvents APPA toxicity. Notably, in addition to the housekeeping APPA-sensitive ThrC (BsThrC), B. subtilis encodes a second threonine synthase (RhiB) encoded within the rhizocticin biosynthetic gene cluster. Kinetic and spectroscopic analyses show that PLP-dependent RhiB is an authentic threonine synthase, converting O-phospho-l-homoserine to threonine with a catalytic efficiency comparable to BsThrC. To understand the structural basis of inhibition, we determined the crystal structure of APPA bound to the housekeeping BsThrC, revealing a covalent complex between the inhibitor and PLP. Structure-based sequence analyses reveal structural determinants within the RhiB active site that contribute to rendering this ThrC homologue resistant to APPA. Together, this work establishes the self-resistance mechanism utilized by B. subtilis ATCC 6633 against APPA exemplifying one of many ways by which bacteria can overcome phosphonate toxicity.

UR - http://www.scopus.com/inward/record.url?scp=85063147176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063147176&partnerID=8YFLogxK

U2 - 10.1021/acschembio.9b00030

DO - 10.1021/acschembio.9b00030

M3 - Article

C2 - 30830751

AN - SCOPUS:85063147176

VL - 14

SP - 742

EP - 750

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 4

ER -